Guangyi Zeng

Peking University — China

Medicine · Health Sciences

9h-index843citations18works26.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(7), Sphingolipid Metabolism and Signaling(6), Gut microbiota and health(4), Cancer, Hypoxia, and Metabolism(4), Advanced Neural Network Applications(3)

Publications18 total

pHNSW: PCA-Based Filtering to Accelerate HNSW Approximate Nearest Neighbor Search
ArXiv.org·2026Open Access
pHNSW: PCA-Based Filtering to Accelerate HNSW Approximate Nearest Neighbor Search
arXiv (Cornell University)·2026Open Access
Intestinal probiotic fungi improve PCOS by sensing metformin signaling and inhibiting gut derived ceramide levels
2026Open Access
Microbial riboflavin inhibits ceramide synthase 3 to lower ceramide (d18:1/26:0) and delay colorectal cancer progression
Cell Metabolism·2025· 9 citedOpen Access
Erratum to “Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism” [Acta Pharm Sin B 14 (2024) 4883–4898]
Acta Pharmaceutica Sinica B·2024· 2 citedOpen Access
Smoking associated metabolites from gut microbiota on health: Nicotine degradation brings hopes
EngMedicine·2024· 1 citedOpen Access
Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism
Acta Pharmaceutica Sinica B·2024· 2 citedOpen Access
Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α
Nature Communications·2024· 12 citedOpen Access
Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Cell·2024· 222 citedOpen Access
When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development
Science China Life Sciences·2024· 19 cited
Sphingosine d18:1 Promotes Nonalcoholic Steatohepatitis by Inhibiting Macrophage HIF-2α
Research Square (Research Square)·2023Open Access
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine
Nature·2022· 191 citedOpen Access
Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation
Acta Pharmaceutica Sinica B·2021· 60 citedOpen Access
Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis
Journal of Clinical Investigation·2021· 118 citedOpen Access
Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner
Redox Biology·2020· 31 citedOpen Access
High‐coverage SARS‐CoV‐2 genome sequences acquired by target capture sequencing
Journal of Medical Virology·2020· 25 citedOpen Access
Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism
Cell Metabolism·2019· 147 citedOpen Access
Target Detection in Colorful Imaging Sonar Based on HOG
2018· 4 cited

Frequent Co-authors

Changtao Jiang(11), Lulu Sun(10), Yanli Pang(6), Song‐Yang Zhang(5), Qixing Nie(4), Bo Chen(4), Jialin Xia(4), Yu Yan(4), Xian Wang(4), Hui‐Ying Liu(3), Pengcheng Wang(3), Frank J. Gonzalez(3), Pengcheng Wang(3), Huiying Liu(3), Xuemei Wang(3), Chuyu Yun(3), Yongqiang Dong(3), Kai Wang(2), Yong Ding(2), Qixiang Zhao(2)